Value Line - The Most Trusted Name in Investment Research - Stock Quotes

Quote Lookup

Please enter a ticker symbol below and click Submit.
Symbol:        VL Survey Page (2014-09-12)Premium Content

Amgen Inc (AMGN)

2014-10-24@20:45:01 ET
Amgen Inc.Corporate Event Announcement Notice (WSH)

2014-10-24@16:16:37 ET
Amgen (AMGN) Trading Near $143.98 Support Level (FBM)

2014-10-24@09:36:54 ET
Pediatric Drugs and Vaccines - 2014 Global Strategic Business Report (MTO)

2014-10-24@09:26:00 ET
Global and China Monoclonal Antibody Industry Report 2014-2019 (MTO)

2014-10-23@20:40:55 ET
Amgen Inc.Corporate Event Announcement Notice (WSH)

2014-10-23@17:39:00 ET
Amgen To Webcast 2014 Business Review Meeting On October 28 (PRN)

2014-10-23@17:08:00 ET
Global Pediatric Drugs and Vaccines Market (PRN)

2014-10-23@17:05:22 ET
SmarTrend Watching for Potential Pullback in Shares of Amgen After 2.51% Gain (PSM)

2014-10-23@17:04:51 ET
Watch for Amgen to Potentially Pullback After Gaining 2.51% Yesterday (PSM)

2014-10-23@16:42:12 ET
Amgen (AMGN) Trading Near $145.98 Resistance Level (FBM)

2014-10-23@16:05:00 ET
Amgen Announces Webcast of 2014 Third Quarter Financial Results (PRN)

2014-10-23@15:12:10 ET
Recent 52-Week High Exceeded in Shares of Amgen (AMGN) (F71)

2014-10-23@12:35:34 ET
Amgen Makes a Move: Up 2.2% (F77)

2014-10-23@12:02:53 ET
Highest Dividend Yield in the Biotechnology Industry Detected for PDL BioPharma (PDLI, THRX, AMGN) (F70)

2014-10-23@11:32:01 ET
Global B-Cell Non-Hodgkin Lymphoma Therapeutics Pipeline Review H2 2014 - 43 Drug Profiles from 28 Leading Pharma Companies (MTO)

2014-10-23@09:30:00 ET
The Zacks Analyst Blog Highlights: AbbVie, Amgen, Regeneron, Pharmacyclics and Repros Therapeutics (PRN)

2014-10-22@17:59:00 ET
Global & USA Cancer Biomarker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis) (PRN)

2014-10-22@17:54:00 ET
Global & USA Cancer Biomarker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis) (PRN)